THUNDEROBOT
872190
Ji Yao Holding Group
300108
Hangzhou Huasu Technology
301157
Flaircomm Microelectronics, Inc.
301600
Jiusheng Electric
301082
CN Stock MarketDetailed Quotes
002755 Beijing Aosaikang Pharmaceutical
- 12.96
- -0.39-2.92%
Not Open Jan 7 15:00 CST
12.03BMarket Cap73.64P/E (TTM)
13.15High12.30Low87.61KlotVolume13.05Open13.35Pre Close110.78MTurnover0.94%Turnover RatioLossP/E (Static)928.16MShares15.1052wk High4.03P/B12.03BFloat Cap6.5052wk Low14.69Limit Up928.15MShs Float41.99Historical High12.02Limit Down6.37%Amplitude4.56Historical Low--Dividend TTM12.64Avg Price40.54KlotAsk--Div YieldTTM100Lot Size42.05KlotBid
Beijing Aosaikang Pharmaceutical News
Osecon: Notice on the acceptance of the application for the subsidiary Malibavir tablets to obtain approval for drug registration and marketing
Osecon: Report for the third quarter of 2024
Osecon: Announcement of Supervisory Board Resolutions
Osecon: Announcement of Board Resolutions
Osecon: Announcement on Subsidiary Nelatinib Maleate Tablets Obtaining a Drug Registration Certificate
Osecon: Announcement on capital increase for holding subsidiaries
Osecon: Announcement of Resolutions of the 15th Meeting of the 6th Board of Directors
Osecon: Semi-Annual Report Board Resolution Announcement
Osecon: Half-year summary table of non-operating capital usage and other related capital transactions
Osecon: 2024 Semi-Annual Report
Osekon: Announcement of Supervisory Board Resolutions in the Semi-Annual Report
Osecon: 2024 semi-annual financial report
Osecon: 2024 Semi-Annual Report Summary
Beijing Aosaikang Pharmaceutical: Announcement regarding the acceptance of the application for the listing permit of the subsidiary's Erlotinib tablets.
Beijing Aosaikang Pharmaceutical: 2024 Interim Performance Forecast
Beijing Aosaikang Pharmaceutical: Announcement regarding subsidiary's pharmaceutical registration certificate for injection of Fosaprepitant Dimeglumine.
Beijing Aosaikang Pharmaceutical: Legal Opinion on the 2023 Annual General Meeting of Shareholders of Beijing Aosaikang Pharmaceutical Co., Ltd.
Beijing Aosaikang Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Beijing Aosaikang Pharmaceutical: Announcement on the subsidiary obtaining a drug registration certificate for injectable isaconazole sulfate
Beijing Aosaikang Pharmaceutical: Verification Report on the 2023 Operating Income Deduction Status Table